Duke, UNC-Chapel Hill scientists identify new antibody for COVID-19 and variants

November 2, 2021
A research collaboration between scientists at Duke University and the University of North Carolina at Chapel Hill has identified and tested an antibody that limits the severity of infections from a variety of coronaviruses, including those that cause COVID-19 as well as the original SARS illness.

The Abstract: November 1, 2021

November 1, 2021

Community partnership provides harm reduction for vulnerable populations in Durban

October 22, 2021
UNC Gillings alum Michael Wilson cofounded Bellhaven Harm Reduction Centre, the first low-threshold harm-reduction center in South Africa which provides community-based health and harm reduction services for low-income and homeless individuals in Durban, South Africa. A recent mini documentary chronicles the unique relationship between the city, nongovernmental organizations (NGOs) and the local university that made this center possible. 

Decarbonization strategies need broader consideration, coordination of energy technologies

October 20, 2021
Deep decarbonization strategies require broad approaches that provide complementary solutions for energy needs across multiple sectors, including electricity, transportation, agriculture, health and manufacturing. Dr. Noah Kittner is lead author on a new commentary that calls for researchers to work together to solve these interdisciplinary challenges.

Meier receives APHA Mid-Career Award in International Health

October 19, 2021
Dr. Benjamin Mason Meier has been selected to receive the 2021 Mid-Career Award in International Health from the American Public Health Association for demonstrated achievement and commitment to international health promotion and development, as well as demonstrated creativity in expanding the concepts pertinent to the practice of public health with an international focus.

Carolina research produces effective experimental pill to treat COVID-19

October 1, 2021
University of North Carolina at Chapel Hill research set the stage to seek emergency authorization of the first oral antiviral drug to treat COVID-19.

Reducing "tobacco swamps" could improve public health

September 30, 2021
Reducing “tobacco swamps” — densely located stores that sell tobacco products — could have a major impact on public health, according to new research.

Partner resistance affects contraceptive use in Kenya

September 21, 2021
The resistance that male partners may have toward contraceptive use contributes to barriers in access for women and birthing people seeking family planning resources in Western Kenya.

Partner violence elevates postpartum viral loads in South Africa

September 14, 2021
Infants can be healthy and HIV-free when their HIV-positive mothers are healthy. Antiretroviral treatment (ART) is the best way to support this outcome, but barriers including partner violence mean that large numbers of women around the world are unable to continue with ART after giving birth.

Digital systems can improve quality of cancer care in low-resource settings

September 7, 2021
Gynecologic cancer contributes significantly to the number of cancer cases each year in Zambia, but weaknesses in referral, communication and coordination systems present challenges to care. Gillings School alumna Katerina Pattee is lead author of a recent article in the Journal of Cancer Policy describing an intervention to establish a low-cost digital system to manage information related to cancer care.

...
5
6
7
1
3
4
8
9
10
11
125
...
RELATED PAGES
CONTACT INFORMATION
Visit our communications and marketing team page.
Contact sphcomm@unc.edu with any media inquiries or general questions.

Communications and Marketing Office
125 Rosenau Hall
CB #7400
135 Dauer Drive
Chapel Hill, NC 27599-7400